86
Views
7
CrossRef citations to date
0
Altmetric
Original Research

New evidence of increased risk of rhinitis in subjects with COPD: a longitudinal population study

, , , , , & show all
Pages 2617-2623 | Published online: 19 Oct 2016

References

  • HellgrenJLillienbergLJarlstedtJKarlssonGTorenKPopulation-based study of non-infectious rhinitis in relation to occupational exposure, age, sex, and smokingAm J Ind Med2002421232812111687
  • CardellLOOlssonPAnderssonMTOTALL: high cost of allergic rhinitis-a national Swedish population-based questionnaire studyNPJ Prim Care Respir Med2016261508226845513
  • BousquetJKhaltaevNCruzAAAllergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)Allergy200863Suppl 86816018331513
  • FokkensWJLundVJMullolJEuropean Position Paper on Rhinosinusitis and Nasal Polyps 2012. A summary for otorhinolaryngologistsRhinology201250111222469599
  • HellgrenJOlinACTorenKIncreased risk of rhinitis symptoms in subjects with gastroesophageal refluxActa Otolaryngol2014134661561924665868
  • ThilsingTRasmussenJLangeBKjeldsenADAl-KalemjiABaelumJChronic rhinosinusitis and occupational risk factors among 20- to 75-year-old Danes-A GA(2) LEN-based studyAm J Ind Med201255111037104322648974
  • NihlenUMontnemeryPAnderssonMSpecific nasal symptoms and symptom-provoking factors may predict increased risk of developing COPDClin Physiol Funct Imaging200828424025018331572
  • Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD)2016 Available from: http://www.goldcopd.org/Accessed January 7, 2016
  • HagstadSBackmanHBjergAPrevalence and risk factors of COPD among never-smokers in two areas of Sweden – occupational exposure to gas, dust or fumes is an important risk factorRespir Med2015109111439144526440676
  • LindbergABjergARonmarkELarssonLGLundbackBPrevalence and underdiagnosis of COPD by disease severity and the attributable fraction of smoking Report from the Obstructive Lung Disease in Northern Sweden StudiesRespir Med2006100226427215975774
  • HalbertRJNatoliJLGanoABadamgaravEBuistASManninoDMGlobal burden of COPD: systematic review and meta-analysisEur Respir J200628352353216611654
  • LundbackBLindbergALindstromMObstructive Lung Disease in Northern Sweden StudiesNot 15 but 50% of smokers develop COPD? – report from the obstructive lung disease in Northern Sweden studiesRespir Med200397211512212587960
  • HansenAGHelvikASThorstensenWMParanasal sinus opacification at MRI in lower airway disease (the HUNT study-MRI)Eur Arch Otorhinolaryngol201627371761176826499376
  • DanielssonPOlafsdottirISBenediktsdottirBGislasonTJansonCThe prevalence of chronic obstructive pulmonary disease in Uppsala, Sweden – the Burden of Obstructive Lung Disease (BOLD) study: cross-sectional population-based studyClin Respir J20126212012721651748
  • NielsenRJohannessenABenediktsdottirBPresent and future costs of COPD in Iceland and Norway: results from the BOLD studyEuro Respir J2009344850857
  • BuistASMcBurnieMAVollmerWMBOLD collaborative research groupInternational variation in the prevalence of COPD (the BOLD Study): a population-based prevalence studyLancet2007370958974175017765523
  • HansenJGPedersenLOvervadKOmlandOJensenHKSorensenHTPrævalensen af kronisk obstruktiv lungesygdom – sekundærpublication [Prevalence of chronic obstructive pulmonary disease–secondary publication]Ugeskr Laeger20091714129862988 Swedish19824224
  • Jyrki-TapaniKSovijarviALundbackBChronic obstructive pulmonary disease in Finland: prevalence and risk factorsCOPD20052333133917146998
  • Standardization of Spirometry, 1994 Update. American Thoracic SocietyAm J Respir Crit Care Med19951523110711367663792
  • OlinACRosengrenAThelleDSLissnerLBakeBTorenKHeight, age, and atopy are associated with fraction of exhaled nitric oxide in a large adult general population sampleChest200613051319132517099006
  • DweikRABoggsPBErzurumSCIrvinCGLeighMWLundbergJOAn official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applicationsAm J Respir Crit Care Med2011184560261521885636
  • MatricardiPMNisiniRPizzoloJGD’AmelioRThe use of Phadiatop in mass-screening programmes of inhalant allergies: advantages and limitationsClin Exp Allergy19902021511552357615
  • DenburgJAvan EedenSFBone marrow progenitors in inflammation and repair: new vistas in respiratory biology and pathophysiologyEur Respir J200627344144516507840
  • BuistASVollmerWMMcBurnieMAWorldwide burden of COPD in high- and low-income countries. Part I. The burden of obstructive lung disease (BOLD) initiativeInt J Tuberc Lung Dis200812770370818544191
  • PrescottELangePVestboJSocioeconomic status, lung function and admission to hospital for COPD: results from the Copenhagen City Heart StudyEur Respir J19991351109111410414412